Bora CDMO Bora CDMO

X

Find Rapastinel manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Rapastinel
Also known as: 117928-94-6, Tppt-amide, Glyx 13, Glyx13, Glyx-13, Rapastinelum
Molecular Formula
C18H31N5O6
Molecular Weight
413.5  g/mol
InChI Key
GIBQQARAXHVEGD-BSOLPCOYSA-N
FDA UNII
6A1X56B95E

Rapastinel has been used in trials studying the treatment of Depressive Disorder, Major and Obsessive-Compulsive Disorder (OCD).
1 2D Structure

Rapastinel

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]pyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C18H31N5O6/c1-9(24)13(19)18(29)23-8-4-6-12(23)17(28)22-7-3-5-11(22)16(27)21-14(10(2)25)15(20)26/h9-14,24-25H,3-8,19H2,1-2H3,(H2,20,26)(H,21,27)/t9-,10-,11+,12+,13+,14+/m1/s1
2.1.3 InChI Key
GIBQQARAXHVEGD-BSOLPCOYSA-N
2.1.4 Canonical SMILES
CC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O
2.1.5 Isomeric SMILES
C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N)N)O
2.2 Other Identifiers
2.2.1 UNII
6A1X56B95E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Glyx-13 Peptide

2. Tppt-amide

2.3.2 Depositor-Supplied Synonyms

1. 117928-94-6

2. Tppt-amide

3. Glyx 13

4. Glyx13

5. Glyx-13

6. Rapastinelum

7. L-threoninamide, L-threonyl-l-prolyl-l-prolyl-

8. Glyx-13 Trifluoroacetate

9. 6a1x56b95e

10. (2s)-1-[(2s)-1-[(2s,3r)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]pyrrolidine-2-carboxamide

11. Glyx-13 Peptide

12. Rapastinel [usan:inn]

13. Unii-6a1x56b95e

14. (s)-n-((2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl)-1-((s)-1-((2s,3r)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide

15. Glyx13;rapastinel

16. Rapastinel(glyx-13)

17. Thr-pro-pro-thr-nh2

18. Rapastinel [inn]

19. Rapastinel [usan]

20. Rapastinel (glyx-13)

21. Rapastinel [who-dd]

22. Schembl1668190

23. Chembl3544917

24. Ex-a794

25. Dtxsid501030481

26. Mfcd12912477

27. S6907

28. Zinc71773625

29. Akos024457610

30. Cs-5507

31. Db11801

32. Ncgc00485669-01

33. Ac-32874

34. As-55920

35. Hy-16728

36. L-threonyl-l-prolyl-l-prolyl-l-threoninamide

37. Q5513673

38. (s)-1-(l-threonyl-l-prolyl)-n-((2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl)pyrrolidine-2-carboxamide

2.4 Create Date
2007-02-09
3 Chemical and Physical Properties
Molecular Weight 413.5 g/mol
Molecular Formula C18H31N5O6
XLogP3-2.8
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass413.22743373 g/mol
Monoisotopic Mass413.22743373 g/mol
Topological Polar Surface Area179 Ų
Heavy Atom Count29
Formal Charge0
Complexity659
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY